Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...

Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions to force lower prices.

When Congress adopted the Inflation Reduction Act (IRA) in 2022, creating the Medicare Drug Price Negotiation Program (MDPNP), the bill did ...

Prior to the law, Medicare paid what the drug companies ... order setting a 30-day deadline for drugmakers to lower the cost of prescription drugs in the U.S. or face new limits over what the ...

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...